Cambridge Polymer Group received a U.S. patent allowance for its injectable hydrogel formulations for biomedical applications. The patent addresses methods for preparing a biocompatible liquid that gels in vivo without chemical reaction. CPG is developing this technology for nucleus pulposus augmentation, orthopedic applications, synthetic tissue models, and tissue bulking.
K2M Introduces a Simplified Minimally Invasive Surgical Technique for Dynamic Stabilization of the Spine
January 27, 2009
April 29, 2009